HCPCS Level IIdrugActive
J0224
Inj. lumasiran, 0.5 mg
BETOS: O1E
Effective: 2021-07-01
Description
Injection, lumasiran, 0.5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Oxlumo
Manufacturer
Alnylam Pharmaceuticals, Inc.
HCPCS Dosage
0.5 MG
Billing Units
189.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.